233 related articles for article (PubMed ID: 32229667)
61. Case Report: A rare case of young adult progressive familial intrahepatic cholestasis-type 3 with a novel heterozygous pathogenic variant of
Zhu H; Wang S; Li L; Geng W; Wan X; Hua R; Wang D; Gao P
Front Pediatr; 2022; 10():1012825. PubMed ID: 36330364
[TBL] [Abstract][Full Text] [Related]
62. Liver diseases related to MDR3 (ABCB4) gene deficiency.
Gonzales E; Davit-Spraul A; Baussan C; Buffet C; Maurice M; Jacquemin E
Front Biosci (Landmark Ed); 2009 Jan; 14(11):4242-56. PubMed ID: 19273348
[TBL] [Abstract][Full Text] [Related]
63. Clinical utility gene card for: progressive familial intrahepatic cholestasis type 3.
Gonzales E; Spraul A; Jacquemin E
Eur J Hum Genet; 2014 Apr; 22(4):. PubMed ID: 24002166
[No Abstract] [Full Text] [Related]
64. Progressive familial intrahepatic cholestasis: a personal perspective.
Knisely AS
Pediatr Dev Pathol; 2000; 3(2):113-25. PubMed ID: 10679031
[TBL] [Abstract][Full Text] [Related]
65. Acute recurrent biliary pancreatitis associated with the ABCB4 gene mutation.
Fein F; Hermelin B; Becker MC; Felix S; Carbonnel F
Gastroenterol Clin Biol; 2007 Jan; 31(1):106-9. PubMed ID: 17273143
[TBL] [Abstract][Full Text] [Related]
66. Functional characterization of ABCB4 mutations found in progressive familial intrahepatic cholestasis type 3.
Park HJ; Kim TH; Kim SW; Noh SH; Cho KJ; Choi C; Kwon EY; Choi YJ; Gee HY; Choi JH
Sci Rep; 2016 Jun; 6():26872. PubMed ID: 27256251
[TBL] [Abstract][Full Text] [Related]
67. Reversal of advanced fibrosis after long-term ursodeoxycholic acid therapy in a patient with residual expression of MDR3.
Frider B; Castillo A; Gordo-Gilart R; Bruno A; Amante M; Alvarez L; Mathet V
Ann Hepatol; 2015; 14(5):745-51. PubMed ID: 26256905
[TBL] [Abstract][Full Text] [Related]
68. Visceral symptoms as a key diagnostic sign for the early infantile form of Niemann-Pick disease type C in a Russian patient: a case report.
Degtyareva AV; Mikhailova SV; Zakharova EY; Tumanova EL; Puchkova AA
J Med Case Rep; 2016 Jun; 10(1):143. PubMed ID: 27250337
[TBL] [Abstract][Full Text] [Related]
69. Novel heterozygous ABCB4 gene mutation causing recurrent first-trimester intrahepatic cholestasis of pregnancy.
Johnston RC; Stephenson ML; Nageotte MP
J Perinatol; 2014 Sep; 34(9):711-2. PubMed ID: 25179380
[TBL] [Abstract][Full Text] [Related]
70. Molecular basis of intrahepatic cholestasis.
Carlton VE; Pawlikowska L; Bull LN
Ann Med; 2004; 36(8):606-17. PubMed ID: 15768832
[TBL] [Abstract][Full Text] [Related]
71. The spectrum of liver diseases related to ABCB4 gene mutations: pathophysiology and clinical aspects.
Davit-Spraul A; Gonzales E; Baussan C; Jacquemin E
Semin Liver Dis; 2010 May; 30(2):134-46. PubMed ID: 20422496
[TBL] [Abstract][Full Text] [Related]
72. Phenotypic spectrum and diagnostic pitfalls of ABCB4 deficiency depending on age of onset.
Schatz SB; Jüngst C; Keitel-Anselmo V; Kubitz R; Becker C; Gerner P; Pfister ED; Goldschmidt I; Junge N; Wenning D; Gehring S; Arens S; Bretschneider D; Grothues D; Engelmann G; Lammert F; Baumann U
Hepatol Commun; 2018 May; 2(5):504-514. PubMed ID: 29761167
[TBL] [Abstract][Full Text] [Related]
73. Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis.
Jansen PL; Strautnieks SS; Jacquemin E; Hadchouel M; Sokal EM; Hooiveld GJ; Koning JH; De Jager-Krikken A; Kuipers F; Stellaard F; Bijleveld CM; Gouw A; Van Goor H; Thompson RJ; Müller M
Gastroenterology; 1999 Dec; 117(6):1370-9. PubMed ID: 10579978
[TBL] [Abstract][Full Text] [Related]
74. Novel
Liu TF; He JJ; Wang L; Zhang LY
World J Clin Cases; 2022 Feb; 10(6):1998-2006. PubMed ID: 35317165
[TBL] [Abstract][Full Text] [Related]
75. Phenotypic variability in Tunisian PFIC3 patients harboring a complex genotype with a differential clinical outcome of UDCA treatment.
Khabou B; Mahjoub B; Barbu V; Balhoudi N; Wardani A; Sfar MT; Fakhfakh F
Clin Chim Acta; 2018 Nov; 486():122-128. PubMed ID: 30036524
[TBL] [Abstract][Full Text] [Related]
76. Liver transplantation for decompensated liver cirrhosis caused by progressive familial intrahepatic cholestasis type 3: A case report.
Xiang D; He J; Wang H; Xiong F; Cheng H; Ai J; Shan R; Wan R; Zhang L; Shi J
Medicine (Baltimore); 2017 Dec; 96(50):e9158. PubMed ID: 29390323
[TBL] [Abstract][Full Text] [Related]
77. Clinical characteristics and genetic profiles of young and adult patients with cholestatic liver disease.
Huynh MT; Nguyen TT; Grison S; Lascols O; Fernandez E; Barbu V
Rev Esp Enferm Dig; 2019 Oct; 111(10):775-788. PubMed ID: 31538484
[TBL] [Abstract][Full Text] [Related]
78. Hydrophilic bile acids prevent liver damage caused by lack of biliary phospholipid in
Wang R; Sheps JA; Liu L; Han J; Chen PSK; Lamontagne J; Wilson PD; Welch I; Borchers CH; Ling V
J Lipid Res; 2019 Jan; 60(1):85-97. PubMed ID: 30416103
[TBL] [Abstract][Full Text] [Related]
79. [Liver disease associated with hereditary defects of hepatobiliary transporters].
Wendum D
Ann Pathol; 2010 Dec; 30(6):426-31. PubMed ID: 21167428
[TBL] [Abstract][Full Text] [Related]
80. ABCB4/MDR3 in health and disease - at the crossroads of biochemistry and medicine.
Prescher M; Kroll T; Schmitt L
Biol Chem; 2019 Sep; 400(10):1245-1259. PubMed ID: 30730833
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
